Literature DB >> 9881601

Sequence analysis suggests the presence of an IG-like domain in the N-terminal region of alpha-dystroglycan which was crystallized after mutation of a protease susceptible site (Arg168-->His).

D Bozic1, J Engel, A Brancaccio.   

Abstract

Recently, we demonstrated that the N-terminal region of mouse alpha-dystroglycan represents an autonomously folding globular domain, organized into at least two subdomains (Brancaccio et al., Eur. J. Biochem. 246, 166-172, 1997). We have now found a similarity between a part of the alpha-dystroglycan N-terminal sequence (approximately from position 80 to 180) and several protein sequences belonging to the immunoglobulin kappa family. Moreover, we have recombinantly expressed and purified a 31 kDa protein fragment which matches the entire alpha-dystroglycan N-terminal globular domain. To prevent the action of bacterial endogenous proteases and/or thrombin, which cleaves the protein into two fragments at an Arg-Ala trypsin-sensitive site in positions 168-169, we have introduced a single mutation (Arg168-->His), thus making the whole domain more stable and suitable for crystallization. Crystals of this mutant protein were obtained by vapor diffusion using the hanging drop technique, and they diffract to 0.28 nm Bragg spacing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881601     DOI: 10.1016/s0945-053x(98)90097-x

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  2 in total

Review 1.  Dystroglycan: emerging roles in mammary gland function.

Authors:  M Lynn Weir; John Muschler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

2.  Protective role for the N-terminal domain of α-dystroglycan in Influenza A virus proliferation.

Authors:  Jessica C de Greef; Bram Slütter; Mary E Anderson; Rebecca Hamlyn; Raul O'Campo Landa; Ellison J McNutt; Yuji Hara; Lecia L Pewe; David Venzke; Kiichiro Matsumura; Fumiaki Saito; John T Harty; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.